Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-01
DOI
10.1186/s13046-018-0916-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter
- (2017) Dian-gang Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects
- (2016) J. Shahbazi et al. CLINICAL CANCER RESEARCH
- OTX015 (MK-8628), a novel BET inhibitor, displaysin vitroandin vivoantitumor effects alone and in combination with conventional therapies in glioblastoma models
- (2016) Caroline Berenguer-Daizé et al. INTERNATIONAL JOURNAL OF CANCER
- B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway
- (2016) Jianheng Wu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- FOXO3a orchestrates glioma cell responses to starvation conditions and promotes hypoxia-induced cell death
- (2016) Daniel P. Brucker et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Expression and prognostic value of the WEE1 kinase in gliomas
- (2016) Darija Music et al. JOURNAL OF NEURO-ONCOLOGY
- Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma
- (2016) Rikke D. Rasmussen et al. Molecular Oncology
- Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
- (2015) Catherine S Grasso et al. NATURE MEDICINE
- Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
- (2015) E. Q. Lee et al. NEURO-ONCOLOGY
- The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells
- (2015) Lotte M.E. Berghauser Pont et al. PLoS One
- Epigenetic dysregulation in glioma
- (2014) Yutaka Kondo et al. CANCER SCIENCE
- BET bromodomain proteins are required for glioblastoma cell proliferation
- (2014) Chiara Pastori et al. Epigenetics
- Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience
- (2014) Pavel Bezecny MEDICAL ONCOLOGY
- Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells
- (2014) W. Fiskus et al. MOLECULAR CANCER THERAPEUTICS
- NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro
- (2013) Wen-juan Wang et al. ACTA PHARMACOLOGICA SINICA
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
- (2013) Z. Cheng et al. CLINICAL CANCER RESEARCH
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets
- (2012) Hua Mao et al. CANCER INVESTIGATION
- Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
- (2011) J. Drappatz et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
- (2011) B. B. Friday et al. NEURO-ONCOLOGY
- Improving RNA-Seq expression estimates by correcting for fragment bias
- (2011) Adam Roberts et al. GENOME BIOLOGY
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
- (2010) Cole Trapnell et al. NATURE BIOTECHNOLOGY
- Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
- (2009) Evanthia Galanis et al. JOURNAL OF CLINICAL ONCOLOGY
- c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells
- (2008) Jialiang Wang et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started